Pomalidomide, bortezomib, and dexamethasone for patients with relapsed or refractory multiple myeloma previously treated with lenalidomide (OPTIMISMM): a randomised, open-label, phase 3 trial

Author:

Richardson Paul G,Oriol Albert,Beksac Meral,Liberati Anna Marina,Galli Monica,Schjesvold Fredrik,Lindsay Jindriska,Weisel Katja,White Darrell,Facon Thierry,San Miguel Jesus,Sunami Kazutaka,O'Gorman Peter,Sonneveld Pieter,Robak Pawel,Semochkin Sergey,Schey Steve,Yu Xin,Doerr Thomas,Bensmaine Amine,Biyukov Tsvetan,Peluso Teresa,Zaki Mohamed,Anderson Kenneth,Dimopoulos Meletios,Abildgaard Niels,Adler Howard,Altuntas Fevzi,Akay Olga Meltem,Amin Bipinkumar,Anagnostopoulos Achilleas,Anderson Larry,Anttila Pekka,Araujo Carla,Arce-Lara Carlos,Aydin Yildiz,Basu Supratik,Battini Ramakrishna,Beeker Thaddeus,Benboubker Lotfi,Ben-Yehuda Dina,Bladé Joan,Blau Igor Wolfgang,Boccia Ralph,Burke Lillian,Byeff Peter,Cascavilla Nicola,Cavo Michele,Chantry Andrew,Charles Yen,Chaudhry Arvind,Corso Alessandro,Coyne Mark,De Arriba Felipe,Delimpasi Sosana,Desjardins Pierre,Dhakal Binod,Di Bartolomeo Paolo,Di Raimondo Francesco,Dürig Jan,Engelhardt Monika,Escoffre-Barbe Martine,Esteves Graca,Flogegard Max,Gabrail Nashat,Gamberi Barbara,Garrison Mitchell,Gay Julie,Gisslinger Heinz,Goldschmidt Hartmut,Goncalves Cristina,Gressot Laurent,Grosicki Sebastian,Hanna Wahid,Hayden Patrick,Henriques Bernardo Maria Manuela,Hermann Robert,Holden Viran,Honkalehto Kirsti,Huben Marianne,Huffman John,Hunter Hannah,Hus Marek,Jagasia Madan,Jagganath Sundar,Janakiram Murali,Jaiyesimi Ishmael,Jenner Matthew,João Cristina,Johnson Peter,Jurcyszyn Artur,Kalayoğlu Beşişik Sevgi,Kambhampati Suman,Kanate Abraham,Karadoğan Ihsan,Khojasteh Ali,Kirkel Dean,Komarnicki Mieczyslaw,Krauth Maria-Theresa,Kuriakose Phillip,Larocca Alessandra,Lauri Birgitta,Leleu Xavier,Lucio Paulo,Luppi Mario,Mangiacavalli Silvia,Mariette Clara,Matsue Kosei,Mellqvist Ulf-Henri,Mendeleeva Larisa,Meshad Michael,Miller Carole,Mohrbacher Ann,Moreau Philippe,Morelli Anna Maria,Müldür Ercan,Naassan Anthony,Nahi Hareth,Nair Rajesh,O'Dwyer Mike,Öngören Aydin Seniz,Openshaw Thomas,O'Rourke Timothy,Osswald Michael,Overton Lindsay,Pati Asmin,Pavic Michel,Pegourie Brigitte,Pehlivan Mustafa,Pierola Ana Alfonso,Plesner Torben,Pluta Andrzej,Rabin Neil,Ramasamy Karthik,Rambaldi Alessandro,Rodriguez Paula,Röllig Christoph,Rosenblatt Jacalyn,Rosenbluth Jonathan,Salomo Morten,Samoylova Olga,Sastre Moral Jose,Sati Hamdi,Selleri Carmine,Shafeek Salim,Shinagawa Atsushi,Sleckman Bethany,Smith Clay,Sonmez Mehmet,Stone Chester,Streetly Matthew,Suzuki Kenshi,Taetle Raymond,Tafuri Agostino,Takezako Naoki,Teke Hava Üsküdar,Vapaatalo Mirja,Vassilopoulos George,Verma Amit,Vidito Sarah,Viterbo Luisa,Vural Filiz,Wang Xiang Sean,Yağci Munci,Yee Andrew

Publisher

Elsevier BV

Subject

Oncology

Cited by 278 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3